Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: A novel approach for overcoming resistance in anticancer treatment-Reference-Cited by-同舟云学术

Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: A novel approach for overcoming resistance in anticancer treatment

Published:2011-09 Issue:1-3 Volume:667 Page:56-65
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Tandon Ruchi,Kapoor Shweta,Vali Shireen,Senthil V.,Nithya D.,Venkataramanan R.,Sharma Ashish,Talwadkar Anay,Ray Abhijit,Bhatnagar Pradip K.,Dastidar Sunanda G.

Publisher

Elsevier BV

Subject

Pharmacology

Reference29 articles.

1. Role of tyrosine kinase inhibitors in cancer therapy;Arora;J. Pharmacol. Exp. Ther.,2005

2. Interference of the IGF system as a strategy to inhibit breast cancer growth;Arteaga;Breast Cancer Res. Treat.,1992

3. The EGF receptor family as targets for breast cancer therapy;Baselga;Breast Cancer Res.,2000

4. The insulin-like growth factor 1 receptor: a key to tumor growth?;Baserga;Cancer Res.,1995

5. IGF-1 receptor in cancer biology;Baserga;Int. J. Cancer,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways;Molecules;2023-09-12

2. Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors;International Journal of Molecular Sciences;2023-05-22

3. Design and Application of Hybrid Polymer-Protein Systems in Cancer Therapy;Polymers;2023-05-08

4. Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer;International Journal of Molecular Sciences;2022-09-08

5. Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer;The Cancer Journal;2022-09